We’re celebrating 175 years of daring scientific innovation—and we’re not done yet. Every day, we’re channeling our passion and resources into delivering innovative therapies that change the face of healthcare. Let’s outdo yesterday. Follow our progress as we accelerate the next generation of cancer treatments at LetsOutdoCancer.com For additional information on our guidelines, please visit http://www.pfizer.com/community-guidelines To apply science and our global resources to improve health and well-being at every stage of life. We strive to provide access to safe and effective and affordable medicines and health care services to the people who need them.

Sectors: Pharmaceutical

[Automatic translation follows] The Digital Health Agency The Agency for Shared Health Information Systems is a state agency under the supervision of the Ministry of Social Affairs and Health, whose objective is to promote the development of information systems in the field of health and the medico-social sector. ASIP Santé aims to contribute to improving the coordination and quality of care. A key player and unifier in e-health, its missions extend from the design and deployment of health information systems, such as the Personal Medical Record (DMP) or telemedicine projects, to project management and management of the Health Professional Card …

[Automatic translation follows] Official account of the Ministry of Health and Access to Care The Ministry of Health and Access to Care prepares and implements the Government's policy in the areas of public health, prevention and access to care. health, solidarity, public administration, poverty, care, and solidarity

Transforming Lives, Every Day. Alexion, AstraZeneca Rare Disease was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. by AstraZeneca. For more than 30 years, Alexion’s mission has been to transform the lives of people affected by rare diseases through the development and delivery of innovative medicines, supportive technologies, and healthcare services. Dedicated to continuing its mission as part of AstraZeneca, Alexion recognizes that patients and caregivers are people first, and by understanding their experiences, Alexion is better able to serve their unique needs. Alexion’s pioneering legacy in rare disease is rooted in being the first to translate the complex …

Sectors: Biotechnology Pharmaceutical

We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in 88 countries. For more information, visit ipsen.com. Pauta exclusiva para México: Clave de Autorización COFEPRIS: 243300201B1962 CONSULTE A SU MÉDICO. Pharmaceuticals, Specialty care: oncology, neuroscience, endocrinology, Research: peptides, toxins, …

Sectors: Pharmaceutical

Head and Neck Expertise. Created in 1905 in the 19th district of Paris, the Adolphe de Rothschild Foundation Hospital is a private health institution of collective interest (ESPIC) specialized in all pathologies of the head and neck for adults and children. This university hospital offers excellent care at a conventional rate (non-profit) and treats nearly 300,000 patients every year. Providing the continuum of care, research and training, the Rothschild Foundation Hospital pilots 125 clinical research studies each year, publishes nearly 300 scientific articles and trains nearly 700 students. The services of the Rothschild Foundation Hospital regularly appear at the top …

Sectors: NGO, Think Tank

Better Health, Brighter Future We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our …

Sectors: Pharmaceutical

Inspired by patients. Driven by science. UCB – Inspired by patients. Driven by science. At UCB, we put our heart, soul and skills into making a difference for people living with severe diseases. We look to transform patients’ lives by pushing the boundaries of what is possible. With us, our talents makes the most of who they are, unlocking innovation and setting new standards for patients. Everything we do starts with a simple question: “How will this make a difference to the lives of people living with severe diseases?” And to find the answers, we connect globally with patients and …